Compile Data Set for Download or QSAR
Report error Found 285 Enz. Inhib. hit(s) with all data for entry = 10634
TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555833(US11345681, Example 1 | 1-[(3S,5R)-5-(methoxymethy...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555834(US11345681, Example 2 | (S)-1-(1-acryloylpyrrolidi...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555835(US11345681, Example 3 | 3-[2-(1-ethyl-2-methyl-1,3...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555836(US11345681, Example 4 | 1-[(3S,5R)-5-(methoxymethy...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555837(US11345681, Example 5 | 1-((3S,5R)-1-acryloyl-5-(m...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555838(US11345681, Example 6 | 1-((3S,5R)-1-acryloyl-5-(m...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555839(US11345681, Example 7 | (S)-1-(1-acryloylpyrrolidi...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555840(US11345681, Example 8 | 1-((3S,5R)-1-acryloyl-5-(m...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555842(US11345681, Example 10 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555843(US11345681, Example 11 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555844(US11345681, Example 12 | 1-((3S,5R)-1-acryloyl-5- ...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555845(US11345681, Example 13 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555846(US11345681, Example 14 | 1-((3S,5R)-1-acryloyl-5-m...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555847(US11345681, Example 15 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555848(US11345681, Example 16 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555849(US11345681, Example 17 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555850(US11345681, Example 18 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555851(US11345681, Example 19 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555852(US11345681, Example 20 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555853(US11345681, Example 21 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555854(US11345681, Example 22 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555855(US11345681, Example 23 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555857(US11345681, Example 25 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555859(US11345681, Example 27 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555860(US11345681, Example 28 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555861(US11345681, Example 29 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555862(US11345681, Example 30 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555863(US11345681, Example 31 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555864(US11345681, Example 32 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555865(US11345681, Example 33 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555866(US11345681, Example 34 | 1-((3S,5S)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555867(US11345681, Example 35 | 1-((3S,5R)-1-acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555869(US11345681, Example 37 | 3-[2-(1-ethyl-6-fluoro-2-...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555870(US11345681, Example 38 | 3-[2-(4-chloro-1-ethyl-2-...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555872(US11345681, Example 40 | 3-[2-(6-fluoro-1-methyl-1...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555874(US11345681, Example 42 | 3-[2-(2-cyclopropyl-1H-1,...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555875(US11345681, Example 43 | 3-[2-(2-cyclopropyl-1-met...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555876(US11345681, Example 44 | 1-[(3S,5R)-5-(methoxymeth...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555877(US11345681, Example 45 | 3-[2-(2-cyclopropyl-1-eth...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555878(US11345681, Example 46 | 3-[2-[4,6-difluoro-2-(tri...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555879(US11345681, Example 47 | 3-[2-[1-(difluoromethyl)-...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555881(US11345681, Example 49 | 3-[2-(2-Amino-1-methyl-1,...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555882(US11345681, Example 50 | 3-[2-(2-Cyclopropyl-4,6-d...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555883(US11345681, Example 51 | 1-((3S,5S)-1-Acryoyl-5-(m...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555884(US11345681, Example 52 | 1-[(3S,5R)-5-(Methoxymeth...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555886(US11345681, Example 54 | 1-((3S,5R)-1-Acryloyl-5-(...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555888(US11345681, Example 56 | 1-[(3S,5R)-5-(Methoxymeth...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555891(US11345681, Example 59 | 3-[2-(1-Tert-butyl-1,3-be...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555892(US11345681, Example 60 | 3-[2-[2-(Dimethylamino)-1...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

TargetFibroblast growth factor receptor 2(Human)
Kinnate Biopharma

US Patent
LigandPNGBDBM555893(US11345681, Example 61 | 3-[2-(2-Cyclopropyl-4,6-d...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 285 total ) | Next | Last >>
Jump to: